Literature DB >> 27976459

Current perspectives in coronary microvascular dysfunction.

Joy S Shome1, Divaka Perera2, Sven Plein1,3, Amedeo Chiribiri1.   

Abstract

The coronary arterial system consists of large epicardial coronary arteries, pre-arterioles, and arterioles, which together closely regulate CBF. Structural, functional, and extravascular abnormalities of the microcirculation lead to CMD. CMD can present with symptoms suggestive of CAD, often in the absence of significant obstructive epicardial CAD. Conventional invasive angiography does not allow direct visualization of the microcirculation. Invasive indices, such as CBF and CFR, and non-invasive imaging modalities, such as CMR and PET, can be used to quantify absolute MBF and enable a direct and accurate assessment of coronary microvascular function. CMD appears to be more prevalent in women, typically presenting with symptoms of ischemia with unobstructed coronary arteries, and has a relatively unfavorable prognosis. CMD is classified clinically depending on the presence or absence of epicardial CAD, myocardial disease, or iatrogenic causes. Although invasive intracoronary techniques can be used to detect CMD, these cannot provide insight into the mechanisms involved in its pathogenesis. Imaging modalities such as CMR and cardiac PET are becoming indispensable tools in the evaluation of suspected CMD.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  microvascular ischemia

Mesh:

Year:  2017        PMID: 27976459     DOI: 10.1111/micc.12340

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  8 in total

Review 1.  Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.

Authors:  Guanghong Jia; Michael A Hill; James R Sowers
Journal:  Circ Res       Date:  2018-02-16       Impact factor: 17.367

Review 2.  Assessment and Treatment for Coronary Microvascular Dysfunction by Contrast Enhanced Ultrasound.

Authors:  Junzhen Zhan; Longhe Zhong; Juefei Wu
Journal:  Front Cardiovasc Med       Date:  2022-06-20

3.  Reduced global myocardial perfusion reserve in DCM and HCM patients assessed by CMR-based velocity-encoded coronary sinus flow measurements and first-pass perfusion imaging.

Authors:  Michael Bietenbeck; Anca Florian; Zornitsa Shomanova; Claudia Meier; Ali Yilmaz
Journal:  Clin Res Cardiol       Date:  2018-05-17       Impact factor: 5.460

4.  HuR/Cx40 downregulation causes coronary microvascular dysfunction in type 2 diabetes.

Authors:  Rui Si; Jody Tori O Cabrera; Atsumi Tsuji-Hosokawa; Rui Guo; Makiko Watanabe; Lei Gao; Yun Sok Lee; Jae-Su Moon; Brian T Scott; Jian Wang; Anthony W Ashton; Jaladanki N Rao; Jian-Ying Wang; Jason X-J Yuan; Ayako Makino
Journal:  JCI Insight       Date:  2021-11-08

Review 5.  Plin5, a New Target in Diabetic Cardiomyopathy.

Authors:  Xiangning Cui; Jingwu Wang; Yang Zhang; Jianliang Wei; Yan Wang
Journal:  Oxid Med Cell Longev       Date:  2022-04-25       Impact factor: 7.310

6.  A novel method for measuring absolute coronary blood flow and microvascular resistance in patients with ischaemic heart disease.

Authors:  Paul D Morris; Rebecca Gosling; Iwona Zwierzak; Holli Evans; Louise Aubiniere-Robb; Krzysztof Czechowicz; Paul C Evans; D Rodney Hose; Patricia V Lawford; Andrew J Narracott; Julian P Gunn
Journal:  Cardiovasc Res       Date:  2021-05-25       Impact factor: 13.081

Review 7.  SGLT2 Inhibitors: A Novel Player in the Treatment and Prevention of Diabetic Cardiomyopathy.

Authors:  Na Li; Hong Zhou
Journal:  Drug Des Devel Ther       Date:  2020-11-06       Impact factor: 4.162

8.  Adeno-associated viral (AAV) vector-mediated therapeutics for diabetic cardiomyopathy - current and future perspectives.

Authors:  Darnel Prakoso; Mitchel Tate; Miles J De Blasio; Rebecca H Ritchie
Journal:  Clin Sci (Lond)       Date:  2021-06-11       Impact factor: 6.124

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.